Identification of domains in human beta-hexosaminidase that determine substrate specificity
- PMID: 8663217
- DOI: 10.1074/jbc.271.29.17377
Identification of domains in human beta-hexosaminidase that determine substrate specificity
Abstract
The lysosomal beta-hexosaminidases are dimers composed of alpha and beta subunits. beta-Hexosaminidase A (alphabeta) is a heterodimer, whereas hexosaminidase B (betabeta) and S (alphaalpha) are homodimers. Although containing a high degree of amino acid identity, each subunit expresses a unique active site that can be distinguished by a differential ability to hydrolyze charged substrates. The site on the beta-subunit primarily degrades neutral substrates, whereas the alpha-subunit site is, in addition, active against sulfated substrates. Isozyme specificity is also exhibited with glycolipid substrates. Among human isozymes, only beta-hexosaminidase A together with the GM2 activator protein can degrade the natural substrate, GM2 ganglioside, at physiologically significant rates. To identify the domains of the human beta-hexosaminidase subunits that determine substrate specificity, we have generated chimeric subunits containing both alpha- and beta-subunit sequences. The chimeric constructs were expressed in HeLa cells to screen for activity and then selected constructs were produced in the baculovirus expression system to assess their ability to degrade GM2 ganglioside in the presence of GM2 activator protein. Generation of activity against the sulfated substrate required the substitution of two noncontinuous alpha-subunit sequences (amino acids 1-191 and 403-529) into analogous positions of the beta-subunit. Chimeric constructs containing only one of these regions linked to the beta-subunit sequence showed either neutral substrate activity only (amino acids 1-191) or lacked enzyme activity entirely (amino acids 403-529). Neither the chimeras nor the wild-type subunits displayed activator-dependent GM2-hydrolyzing activity when expressed alone. However, one chimeric subunit containing alpha amino acids 1-191 fused with beta amino acids 225 to 556, when co-expressed with the wild-type alpha-subunit, showed activity comparable with that of recombinant beta-hexosaminidase A formed by the co-expression of the alpha- and beta-subunits. This result indicates that the beta-subunit amino acids 225-556 contribute an essential function in the GM2-hydrolyzing activity of beta-hexosaminidase A.
Similar articles
-
Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins.Biochemistry. 1996 Aug 20;35(33):10894-903. doi: 10.1021/bi960503a. Biochemistry. 1996. PMID: 8718882
-
Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.Biochemistry. 1996 Apr 2;35(13):3963-9. doi: 10.1021/bi9524575. Biochemistry. 1996. PMID: 8672428
-
A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.Biochim Biophys Acta. 2003 Jan 20;1637(1):113-8. doi: 10.1016/s0925-4439(02)00221-1. Biochim Biophys Acta. 2003. PMID: 12527415 Free PMC article.
-
Biochemical consequences of mutations causing the GM2 gangliosidoses.Biochim Biophys Acta. 1999 Oct 8;1455(2-3):105-38. doi: 10.1016/s0925-4439(99)00074-5. Biochim Biophys Acta. 1999. PMID: 10571007 Review.
-
Biochemical characterization of the GM2 gangliosidosis B1 variant.Braz J Med Biol Res. 2004 Jun;37(6):777-83. doi: 10.1590/s0100-879x2004000600001. Epub 2004 May 27. Braz J Med Biol Res. 2004. PMID: 15264019 Review.
Cited by
-
CNS-targeted base editing of the major late-onset Tay-Sachs mutation alleviates disease in mice.J Clin Invest. 2025 Jun 17;135(16):e183434. doi: 10.1172/JCI183434. eCollection 2025 Aug 15. J Clin Invest. 2025. PMID: 40526437 Free PMC article.
-
Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.J Mol Biol. 2003 Apr 11;327(5):1093-109. doi: 10.1016/s0022-2836(03)00216-x. J Mol Biol. 2003. PMID: 12662933 Free PMC article.
-
Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.Orphanet J Rare Dis. 2023 Mar 13;18(1):52. doi: 10.1186/s13023-023-02637-1. Orphanet J Rare Dis. 2023. PMID: 36907859 Free PMC article.
-
Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.J Clin Invest. 2016 May 2;126(5):1691-703. doi: 10.1172/JCI85300. Epub 2016 Mar 28. J Clin Invest. 2016. PMID: 27018595 Free PMC article.
-
Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Efficiently Rescues GM2 Ganglioside Accumulation in Tay-Sachs Disease.J Pers Med. 2025 May 10;15(5):196. doi: 10.3390/jpm15050196. J Pers Med. 2025. PMID: 40423067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases